Cite

HARVARD Citation

    Kopylov, U. et al. (2019). Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience. Digestive and liver disease. 51 (1), pp. 68-74. [Online]. 
  
Back to record